• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia.

作者信息

Kazumi T, Yoshino G, Kasama T, Iwatani I, Iwai M, Morita S, Baba S

出版信息

Horm Metab Res. 1986 Sep;18(9):654-5. doi: 10.1055/s-2007-1012398.

DOI:10.1055/s-2007-1012398
PMID:3096862
Abstract
摘要

相似文献

1
Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia.
Horm Metab Res. 1986 Sep;18(9):654-5. doi: 10.1055/s-2007-1012398.
2
Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.普伐他汀和吉非贝齐治疗家族性高胆固醇血症患者后的血浆脂蛋白变化
J Lab Clin Med. 1989 Sep;114(3):250-9.
3
[Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].[苯扎贝特对原发性高胆固醇血症患者脂蛋白脂质及载脂蛋白B和A1的影响]
Clin Ter. 1987 Jul 15;122(1):17-23.
4
[Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia].[HMG-CoA还原酶抑制剂普伐他汀与考来烯胺治疗高胆固醇血症的疗效比较]
Arzneimittelforschung. 1990 Dec;40(12):1322-7.
5
Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type II.
Eur J Clin Pharmacol. 1990;39(2):101-5. doi: 10.1007/BF00280040.
6
[Evaluation of apoproteins A and B, lipoproteins and plasma lipids during treatment with bezafibrate in various forms of hyperlipoproteinemia].
Clin Ter. 1988 Mar 15;124(5):373-81.
7
Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.HMG CoA还原酶抑制剂普伐他汀和胆汁酸螯合剂考来烯胺对由载脂蛋白组成所定义的脂蛋白颗粒的影响。
Metabolism. 1990 Mar;39(3):269-73. doi: 10.1016/0026-0495(90)90046-f.
8
Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.吉非贝齐治疗原发性II型高脂蛋白血症：对脂质、脂蛋白和载脂蛋白的影响。
Can J Cardiol. 1991 Jan-Feb;7(1):27-33.
9
The relationship between apolipoprotein B-100 and low-density lipoprotein cholesterol after treatment with an HMG CoA reductase inhibitor.使用HMG CoA还原酶抑制剂治疗后载脂蛋白B - 100与低密度脂蛋白胆固醇之间的关系。
Am J Clin Pathol. 1989 Oct;92(4):479-83. doi: 10.1093/ajcp/92.4.479.
10
Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.两种HMG-CoA还原酶抑制剂（洛伐他汀和普伐他汀）对血脂和脂蛋白的比较作用。
Int J Tissue React. 1991;13(2):107-10.

引用本文的文献

1
Pravastatin: a review of its use in elderly patients.普伐他汀：老年患者用药综述
Drugs Aging. 2003;20(14):1061-82. doi: 10.2165/00002512-200320140-00005.
2
Pravastatin. A reappraisal of its pharmacological properties and clinical effectiveness in the management of coronary heart disease.普伐他汀。对其在冠心病管理中的药理特性和临床疗效的重新评估。
Drugs. 1997 Feb;53(2):299-336. doi: 10.2165/00003495-199753020-00008.
3
Pravastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia.
普伐他汀。其在高胆固醇血症中的药理特性及治疗潜力综述。
Drugs. 1991 Jul;42(1):65-89. doi: 10.2165/00003495-199142010-00005.
4
Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia.洛伐他汀和普伐他汀单独及与考来烯胺联合应用对原发性高胆固醇血症患者血脂、脂蛋白和载脂蛋白的短期及长期影响
Eur J Clin Pharmacol. 1992;42(4):353-8. doi: 10.1007/BF00280117.